Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Omeros Corp.
DescriptionPlasmin inhibitor
Molecular Target Plasmin
Mechanism of ActionSerine protease inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationBleeding
Indication DetailsReduce blood loss during cardiovascular surgery
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today